Why Illumina Jumped 9.8% in November
Shares of the genomic sequencing specialist Illumina (NASDAQ: ILMN) rose nearly 10% in November, according to data from S&P Global Market Intelligence. However, there wasn't any company-specific news that can justify the move. Shareholders can likely chalk up the jump to continued enthusiasm for the company's breakout year.
Image source: Getty Images.
While there wasn't any big news released during the month, the company did have a few positive announcements to make, including:
Source: Fool.com
Illumina Inc. Stock
€161.62
-0.680%
With 19 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
With a target price of 179 € there is a slightly positive potential of 10.75% for Illumina Inc. compared to the current price of 161.62 €.


